Italian Competition Watchdog Investigates EasyJet Over Baggage Pricing Practices Elon Musk Loses OpenAI Lawsuit Yet Legal Battles Likely to Continue Kevin Warshs Potential Fed Policy Shift A Slimmer Role in Wall Streets Plumbing Signos Raises 20M in Funding Expands Dexcom Partnership to Capitalize on GLP1 Weight Loss Trend Egg Price Surge How Inflation and Supply Disruptions Raised the Cost of a Staple Japanese Shipbuilding Town Turns to Foreign Workers and AI to Tackle Labor Shortage Disc Medicine IRON Q1 2026 Earnings SmallerThanExpected Loss Reflects Continued Cost Discipline in PreRevenue Stage HTZ Q1 2026 Earnings NarrowerthanExpected Loss Lifts Shares VNDA Q1 2026 Earnings EPS Misses Estimates as Operating Costs Weigh on Results PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response MSA Safety MSA Q1 2026 Earnings Solid EPS Beat Amid Steady Demand SBAC Q1 2026 Earnings EPS Misses Estimates Amid Challenging Leasing Environment Eaton Corporation ETN Gains Momentum Technical and Fundamental Drivers Behind the Uptrend Lulus Fashion Lounge LVLU Dips Nearly 4 as Stock Approaches Key Support Levels Launch One Acquisition Corp LPAA Holds Steady Near Resistance Amid Quiet Trading Enpro Inc NPO Surges 32 as Shares Test Key Resistance Zone Enlivex Ltd ENLV Rallies 14 Key Levels and Technical Outlook TTK Prestige Reports 45 Surge in FY26 Net Profit Driven by Strong Demand and Product Expansion Phibro Animal Health PAHC Q1 2026 Earnings EPS Surges Past Estimates Stock Dips Despite Beat Reliance Global Group EZRA Slips 325 Amid Consolidation Near Key Support ASND Q1 2026 Earnings Wide EPS Miss as Ascendis Pharma Remains PreRevenue Stock Edges Higher CRC Q1 2026 Earnings EPS Beats Estimates Stock Slides amid Market Headwinds YPF Q4 2025 Earnings Massive Reported Loss Despite Positive Stock Movement Seaport Entertainment Group Inc SEG Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage DUOL Q1 2026 Earnings EPS Beats Estimates by 164 Stock Edges Higher VECO Q1 2026 Earnings EPS Misses Estimates by Over 40 Shares Edge Lower InMed Pharmaceuticals Q3 2025 Earnings Net Loss Widens Amid Pipeline Focus